The Swiss Pharmaceuticals sector produced four USD1 billion+ deals in the first half of 2018. This is not surprising given the efforts by Pharmaceuticals and Life Sciences businesses to push new boundaries and continuously innovate.
The post Swap, don’t sell: Driving value through asset swaps appeared first on Expert Blog.
